Saturday 31 October 2026 Export MRNA’s income statement to Excel — free account

Moderna, Inc.

MRNA Healthcare Biotechnology

Moderna, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, down 39.9% from fiscal 2024.

Revenue: +2.11%
EPS: +7.51%
Free cash flow: +38.9%
Total debt: +1,765.6%

Quarter to June 2026, against a year earlier

221.72 1.04 −0.47%

Follow MRNA

Alert me

Market cap: $88.9B
P/E: 0.0×
Fwd P/E: −26.1×
Dividend yield: —
F-score: 3/9
Altman Z: 2.46
Beneish M: −3.52
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Filings

Moderna, Inc. (MRNA) P/E ratio

Alert me on P/E ratio

Moderna, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 161× (June 2021) — the current reading is the lowest in ten years.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/MRNA/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Moderna, Inc. P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/MRNA/metrics/pe-ratio">Moderna, Inc. (MRNA) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	0.0×	—
FY2024	0.0×	—
FY2023	0.0×	—
FY2022	8.5×	0.99%
FY2021	8.4×	—
FY2020	0.0×	—
FY2019	0.0×	—
FY2018	0.0×	—
FY2017	0.0×	—
FY2016	0.0×	—

Period	P/E ratio	Change
Jun 2026	0.0×	—
Mar 2026	0.0×	—
Dec 2025	0.0×	—
Sep 2025	0.0×	—
30 more quarters	Free account

Against its own ten years

Low 0.0× High 161×

Ten-year median 0.0×

Current reading's percentile 68

Company	P/E ratio
ROIV Roivant Sciences Ltd. compare	n/m
RVMD Revolution Medicines, Inc. compare	n/m
MRNA Moderna, Inc.	n/m
REGN Regeneron Pharmaceuticals, Inc. compare	22.1×
VRTX Vertex Pharmaceuticals Incorporated compare	32.3×
ARGX argenex SE compare	32.5×
RPRX Royalty Pharma PLC compare	36.1×
GMAB Genmab A/S Sponsored ADR compare	44.9×
ONC BeOne Medicines Ltd. - Sponsored ADR compare	62.9×
Biotechnology industry median	12.4×
Healthcare sector median	25.8×
Market median	18.6×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

Moderna, Inc. (MRNA) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on MRNA

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on MRNA

Stockrow Weekly